Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Memory Loss Clinical Trials

A listing of Memory Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (62) clinical trials

The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype.

Phase

Multi-center, randomized, double-blind, parallel-group,placebo-controlled study to evaluate the safety and tolerability, efficacy, and PK of 60 mg and 90 mg AD-35 administered QD during 6 months of double-blind treatment followed by a second 6 months of open-label treatment to subjects with mild to moderate AD.  

Phase

Participate in a clinical trial exploring memory loss at ActivMed Practices and Research, Inc. in Methuen, MA.  

Phase

Are you starting to experience memory problems? Are slight memory problems affecting your ability to do regular activities? Has anyone noticed a change in your memory? Do you have a family history of Alzheimer’s Disease? If so, you may be experiencing the first signs of memory loss. You may qualify ...

Phase

Clinical research study of an investigational drug that may help slow or stop memory loss in people with early stages of Alzheimer's disease.  

Phase

Effectiveness of study drug  LY3154207 on cognition and memory in person's with Mild to Moderate Parkinson's Disease Dementia (PDD)  

Phase

A research study is evaluating an investigational medication for early symptoms of Alzheimer’s Disease.

Phase N/A

The purpose of this study is to determine the safety and efficacy of TRx0237 8 mg/day in the treatment of subjects with mild Alzheimer's Disease compared to placebo.

Phase

This is a Phase II, randomised, multi-centre, double-blind, placebo-controlled proof-of-concept study to assess the safety, tolerability and efficacy of oral Xanamem™ once daily in adult subjects with mild dementia due to AD.

Phase

Effects of Music and Dance on Cognition Frailty and Burden in Elderly Caregivers Living in Rural Communities

Sample Variables above described of 58 participants will be measured. The participants will be randomized to the dance group (experimental) and to the health care guidance group (control). The group will be paired by age, sex, and schooling. This study focused on prevention of cognitive performance decline, frailty and burden.

Phase N/A